Our medical implants technology leverages nature-derived biopolymers to prevent postoperative adhesions, enhancing surgical outcomes by harnessing the anti-fibrinolytic properties of inherent phenolic compounds.
Headquarters:
Singapore
Company Type:
SME
Company size:
1-10 Employees
Year Founded:
2019 (7 years)
Address:
2 VENTURE DRIVE; #24-01, VISION EXCHANGE; SINGAPORE, 608526, SG
The company is owned by individual shareholder(s), it has no corporate shareholder.
LOW
spending power